In conclusion, the results of our study revealed that PPT treatment was able to effectively induce apoptosis by regulating anti- and pro-apoptotic proteins in human ESCC cells via the JNK/p38 MAPK signaling pathways, which demonstrated the detailed anti-cancer mechanism of PPT in human ESCC cells. The gene discussed is MAPK8; the disease is cancer.